Company Data
Lipella Pharmaceuticals Inc.
Ticker
LIPO
Current Price
$2.78 -7.02%
Market Cap
$12.4M
Price Target
Refer to Report
Volume
25.3K
52wk Range
$1.965 - $12
Overview
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.